Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-18
1996-11-19
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142358, 514252, 514326, 514333, 514341, 544139, 544370, 546210, 546256, 5462747, 5462751, 5483381, A61K 31535, A61K 31415, C07D41310, C07D40310
Patent
active
055763421
ABSTRACT:
Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives are prepared by reacting phenylacetic acids with glycinamides. The compounds can be used as active compounds in medicaments.
REFERENCES:
patent: 5128355 (1992-07-01), Carini et al.
patent: 5352687 (1994-10-01), Muller et al.
patent: 5420149 (1995-05-01), Muller et al.
The Journal of Cell Biology, vol. 50, 1971, pp. 172-186; "The Smooth Muscle Cell . . . ", R. Ross.
McGraw-Hill Series in Advanced Chemistry, 1962; "Stereochemistry of Carbon Compounds", E. L. Eliel, 6 pages.
Chemical Abstracts, vol. 81, 1974, p. 577, 34--Amino Acids/Peptides/Proteins; CA#169829k: "Chemistry and mechanism of new angiotensin II antagonists", H. Wissmann et al.
Beuck Martin
Dressel J urgen
Fey Peter
H ubsch Walter
Hanko Rudolf
Bayer Aktiengesellschaft
Morris Patricia L.
LandOfFree
Phenylglycinamides of heterocyclically substitued phenylacetic a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylglycinamides of heterocyclically substitued phenylacetic a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylglycinamides of heterocyclically substitued phenylacetic a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-541374